{"id":43823,"date":"2020-12-07T08:01:31","date_gmt":"2020-12-07T13:01:31","guid":{"rendered":"https:\/\/cablemanpro.com\/wallstreetpr\/?p=43823"},"modified":"2020-12-07T01:04:01","modified_gmt":"2020-12-07T06:04:01","slug":"pfizer-inc-nysepfe-cuts-its-projected-number-of-covid-19-vaccines-doses-for-2020-because-of-production-challenges","status":"publish","type":"post","link":"https:\/\/cablemanpro.com\/wallstreetpr\/pfizer-inc-nysepfe-cuts-its-projected-number-of-covid-19-vaccines-doses-for-2020-because-of-production-challenges-43823","title":{"rendered":"Pfizer Inc. (NYSE:PFE) Cuts Its Projected Number Of COVID-19 Vaccines Doses For 2020 Because Of Production Challenges"},"content":{"rendered":"<p><strong>Pfizer Inc. (NYSE:PFE)<\/strong> has announced that it will ship only half of the initially expected coronavirus vaccine doses this year due to supply chain problems. The company is developing a COVID-19 vaccine in partnership with Germany-based <strong>BioNTech SE (NASDAQ:BNTX).<\/strong><\/p>\n<p><strong>Pfizer to deliver 50 million vaccine doses this year <\/strong><\/p>\n<p>The pharmaceutical giant has slashed its initial distribution <a href=\"https:\/\/nypost.com\/2020\/12\/03\/pfizer-cuts-covid-19-vaccine-rollout-target-in-half-after-supply-chain-issues\/\" target=\"_blank\" rel=\"noopener noreferrer\">target of 100 million doses<\/a> globally by the end of 2020 to around 50 million doses. However, the company is optimistic that it will roll out more than one billion doses by 2021. Pfizer spokeswoman said that expansion of the raw material supply chain took more time than expected. Therefore it is important to note that the clinical trial outcome was somehow late than its initial projection.<\/p>\n<p>On December 2, 2020, the UK granted Pfizer&#8217;s vaccine emergency use authorization becoming the first country in the western world to administer the vaccine. Pfizer&#8217;s two-shot inoculation is currently under review by the US FDA, where emergency user authorization is expected later this month with roll-out anticipated before year-end.<\/p>\n<p><strong>The US targeted 40 million COVID-19 doses by the end of 2020<\/strong><\/p>\n<p>The US was planning to <a href=\"https:\/\/www.wsj.com\/articles\/pfizer-slashed-its-covid-19-vaccine-rollout-target-after-facing-supply-chain-obstacles-11607027787\" target=\"_blank\" rel=\"noopener noreferrer\">distribute 6.4 million doses<\/a> of the Pfizer vaccine after authorization. It is unclear how the delay will affect the distribution considering the US had a target of distributing 40 million doses from Pfizer and <strong>Moderna (NASDAQ:MRNA) <\/strong>by the end of 2020. An individual involved in developing the Pfizer vaccines said the delays are dues to failure if early raw material batches meet standards. However, they fixed the problems but ran out of time to meet projected shipments before the year ends.<\/p>\n<p>Pfizer gets raw materials for the production of the vaccine from US and European providers. Unfortunately, there was a problem with scaling up the raw materials&#8217; production as Pfizer waited for data from trials. Study results showed the Pfizer vaccine to be effective and well-tolerated. The company has not given the specifics where the shortfalls over raw materials were in scaling production.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Pfizer Inc. (NYSE:PFE) has announced that it will ship only half of the initially expected coronavirus vaccine doses this year due to supply chain problems. [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":41971,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"rop_custom_images_group":[],"rop_custom_messages_group":[],"rop_publish_now":"initial","rop_publish_now_accounts":{"twitter_2902945987_2902945987":""},"rop_publish_now_history":[],"rop_publish_now_status":"pending","footnotes":""},"categories":[264],"tags":[14736,14735,14729,993,2745,3275],"stock_ticker":[],"class_list":["post-43823","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-health","tag-biontech-se","tag-biontech-se-nasdaqbntx","tag-nasdaqbntx","tag-nysepfe","tag-pfizer-inc-nysepfe","tag-pfizer-inc","entry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Pfizer Inc. (NYSE:PFE) Cuts Its Projected Number Of COVID-19 Vaccines Doses For 2020 Because Of Production Challenges - Wall Street PR<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/cablemanpro.com\/wallstreetpr\/pfizer-inc-nysepfe-cuts-its-projected-number-of-covid-19-vaccines-doses-for-2020-because-of-production-challenges-43823\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Pfizer Inc. (NYSE:PFE) Cuts Its Projected Number Of COVID-19 Vaccines Doses For 2020 Because Of Production Challenges - Wall Street PR\" \/>\n<meta property=\"og:description\" content=\"Pfizer Inc. (NYSE:PFE) has announced that it will ship only half of the initially expected coronavirus vaccine doses this year due to supply chain problems. [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/cablemanpro.com\/wallstreetpr\/pfizer-inc-nysepfe-cuts-its-projected-number-of-covid-19-vaccines-doses-for-2020-because-of-production-challenges-43823\" \/>\n<meta property=\"og:site_name\" content=\"Wall Street PR\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/WallStreetPR\/\" \/>\n<meta property=\"article:published_time\" content=\"2020-12-07T13:01:31+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/07\/Pfizer-Inc..jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"660\" \/>\n\t<meta property=\"og:image:height\" content=\"440\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Donna Fago\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Donna Fago\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/pfizer-inc-nysepfe-cuts-its-projected-number-of-covid-19-vaccines-doses-for-2020-because-of-production-challenges-43823#article\",\"isPartOf\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/pfizer-inc-nysepfe-cuts-its-projected-number-of-covid-19-vaccines-doses-for-2020-because-of-production-challenges-43823\"},\"author\":{\"name\":\"Donna Fago\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/60ece280249b1fa366ae54f87bb8ae84\"},\"headline\":\"Pfizer Inc. (NYSE:PFE) Cuts Its Projected Number Of COVID-19 Vaccines Doses For 2020 Because Of Production Challenges\",\"datePublished\":\"2020-12-07T13:01:31+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/pfizer-inc-nysepfe-cuts-its-projected-number-of-covid-19-vaccines-doses-for-2020-because-of-production-challenges-43823\"},\"wordCount\":340,\"publisher\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/pfizer-inc-nysepfe-cuts-its-projected-number-of-covid-19-vaccines-doses-for-2020-because-of-production-challenges-43823#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/07\/Pfizer-Inc..jpg\",\"keywords\":[\"BioNTech SE\",\"BioNTech SE (NASDAQ:BNTX)\",\"NASDAQ:BNTX\",\"NYSE:PFE\",\"Pfizer Inc (NYSE:PFE)\",\"Pfizer Inc.\"],\"articleSection\":[\"Health\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/pfizer-inc-nysepfe-cuts-its-projected-number-of-covid-19-vaccines-doses-for-2020-because-of-production-challenges-43823\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/pfizer-inc-nysepfe-cuts-its-projected-number-of-covid-19-vaccines-doses-for-2020-because-of-production-challenges-43823\",\"name\":\"Pfizer Inc. (NYSE:PFE) Cuts Its Projected Number Of COVID-19 Vaccines Doses For 2020 Because Of Production Challenges - Wall Street PR\",\"isPartOf\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/pfizer-inc-nysepfe-cuts-its-projected-number-of-covid-19-vaccines-doses-for-2020-because-of-production-challenges-43823#primaryimage\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/pfizer-inc-nysepfe-cuts-its-projected-number-of-covid-19-vaccines-doses-for-2020-because-of-production-challenges-43823#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/07\/Pfizer-Inc..jpg\",\"datePublished\":\"2020-12-07T13:01:31+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/pfizer-inc-nysepfe-cuts-its-projected-number-of-covid-19-vaccines-doses-for-2020-because-of-production-challenges-43823#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/cablemanpro.com\/wallstreetpr\/pfizer-inc-nysepfe-cuts-its-projected-number-of-covid-19-vaccines-doses-for-2020-because-of-production-challenges-43823\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/pfizer-inc-nysepfe-cuts-its-projected-number-of-covid-19-vaccines-doses-for-2020-because-of-production-challenges-43823#primaryimage\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/07\/Pfizer-Inc..jpg\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/07\/Pfizer-Inc..jpg\",\"width\":660,\"height\":440},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/pfizer-inc-nysepfe-cuts-its-projected-number-of-covid-19-vaccines-doses-for-2020-because-of-production-challenges-43823#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Pfizer Inc. (NYSE:PFE) Cuts Its Projected Number Of COVID-19 Vaccines Doses For 2020 Because Of Production Challenges\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#website\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\",\"name\":\"Wall Street PR\",\"description\":\"Latest News From WallStreet\",\"publisher\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/cablemanpro.com\/wallstreetpr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\",\"name\":\"Wall Street PR\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png\",\"width\":537,\"height\":70,\"caption\":\"Wall Street PR\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/WallStreetPR\/\",\"https:\/\/x.com\/WallstreetPRs\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/60ece280249b1fa366ae54f87bb8ae84\",\"name\":\"Donna Fago\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/06\/f15db860f556e28a86f628554c98485b.jpeg\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/06\/f15db860f556e28a86f628554c98485b.jpeg\",\"caption\":\"Donna Fago\"},\"description\":\"I believe in writing content Informing investors with the knowledge they need to invest better today- I have been following the markets for many years and was asked to join the team at WallStreetPR.com recently due to my passion for the markets.\",\"sameAs\":[\"http:\/\/www.WallStreetPR.com\"],\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/author\/darcie-fago\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Pfizer Inc. (NYSE:PFE) Cuts Its Projected Number Of COVID-19 Vaccines Doses For 2020 Because Of Production Challenges - Wall Street PR","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/cablemanpro.com\/wallstreetpr\/pfizer-inc-nysepfe-cuts-its-projected-number-of-covid-19-vaccines-doses-for-2020-because-of-production-challenges-43823","og_locale":"en_US","og_type":"article","og_title":"Pfizer Inc. (NYSE:PFE) Cuts Its Projected Number Of COVID-19 Vaccines Doses For 2020 Because Of Production Challenges - Wall Street PR","og_description":"Pfizer Inc. (NYSE:PFE) has announced that it will ship only half of the initially expected coronavirus vaccine doses this year due to supply chain problems. [&hellip;]","og_url":"https:\/\/cablemanpro.com\/wallstreetpr\/pfizer-inc-nysepfe-cuts-its-projected-number-of-covid-19-vaccines-doses-for-2020-because-of-production-challenges-43823","og_site_name":"Wall Street PR","article_publisher":"https:\/\/www.facebook.com\/WallStreetPR\/","article_published_time":"2020-12-07T13:01:31+00:00","og_image":[{"width":660,"height":440,"url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/07\/Pfizer-Inc..jpg","type":"image\/jpeg"}],"author":"Donna Fago","twitter_misc":{"Written by":"Donna Fago","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/pfizer-inc-nysepfe-cuts-its-projected-number-of-covid-19-vaccines-doses-for-2020-because-of-production-challenges-43823#article","isPartOf":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/pfizer-inc-nysepfe-cuts-its-projected-number-of-covid-19-vaccines-doses-for-2020-because-of-production-challenges-43823"},"author":{"name":"Donna Fago","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/60ece280249b1fa366ae54f87bb8ae84"},"headline":"Pfizer Inc. (NYSE:PFE) Cuts Its Projected Number Of COVID-19 Vaccines Doses For 2020 Because Of Production Challenges","datePublished":"2020-12-07T13:01:31+00:00","mainEntityOfPage":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/pfizer-inc-nysepfe-cuts-its-projected-number-of-covid-19-vaccines-doses-for-2020-because-of-production-challenges-43823"},"wordCount":340,"publisher":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/pfizer-inc-nysepfe-cuts-its-projected-number-of-covid-19-vaccines-doses-for-2020-because-of-production-challenges-43823#primaryimage"},"thumbnailUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/07\/Pfizer-Inc..jpg","keywords":["BioNTech SE","BioNTech SE (NASDAQ:BNTX)","NASDAQ:BNTX","NYSE:PFE","Pfizer Inc (NYSE:PFE)","Pfizer Inc."],"articleSection":["Health"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/pfizer-inc-nysepfe-cuts-its-projected-number-of-covid-19-vaccines-doses-for-2020-because-of-production-challenges-43823","url":"https:\/\/cablemanpro.com\/wallstreetpr\/pfizer-inc-nysepfe-cuts-its-projected-number-of-covid-19-vaccines-doses-for-2020-because-of-production-challenges-43823","name":"Pfizer Inc. (NYSE:PFE) Cuts Its Projected Number Of COVID-19 Vaccines Doses For 2020 Because Of Production Challenges - Wall Street PR","isPartOf":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/pfizer-inc-nysepfe-cuts-its-projected-number-of-covid-19-vaccines-doses-for-2020-because-of-production-challenges-43823#primaryimage"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/pfizer-inc-nysepfe-cuts-its-projected-number-of-covid-19-vaccines-doses-for-2020-because-of-production-challenges-43823#primaryimage"},"thumbnailUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/07\/Pfizer-Inc..jpg","datePublished":"2020-12-07T13:01:31+00:00","breadcrumb":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/pfizer-inc-nysepfe-cuts-its-projected-number-of-covid-19-vaccines-doses-for-2020-because-of-production-challenges-43823#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/cablemanpro.com\/wallstreetpr\/pfizer-inc-nysepfe-cuts-its-projected-number-of-covid-19-vaccines-doses-for-2020-because-of-production-challenges-43823"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/pfizer-inc-nysepfe-cuts-its-projected-number-of-covid-19-vaccines-doses-for-2020-because-of-production-challenges-43823#primaryimage","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/07\/Pfizer-Inc..jpg","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/07\/Pfizer-Inc..jpg","width":660,"height":440},{"@type":"BreadcrumbList","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/pfizer-inc-nysepfe-cuts-its-projected-number-of-covid-19-vaccines-doses-for-2020-because-of-production-challenges-43823#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/cablemanpro.com\/wallstreetpr\/"},{"@type":"ListItem","position":2,"name":"Pfizer Inc. (NYSE:PFE) Cuts Its Projected Number Of COVID-19 Vaccines Doses For 2020 Because Of Production Challenges"}]},{"@type":"WebSite","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#website","url":"https:\/\/cablemanpro.com\/wallstreetpr\/","name":"Wall Street PR","description":"Latest News From WallStreet","publisher":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/cablemanpro.com\/wallstreetpr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization","name":"Wall Street PR","url":"https:\/\/cablemanpro.com\/wallstreetpr\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png","width":537,"height":70,"caption":"Wall Street PR"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/WallStreetPR\/","https:\/\/x.com\/WallstreetPRs"]},{"@type":"Person","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/60ece280249b1fa366ae54f87bb8ae84","name":"Donna Fago","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/image\/","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/06\/f15db860f556e28a86f628554c98485b.jpeg","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/06\/f15db860f556e28a86f628554c98485b.jpeg","caption":"Donna Fago"},"description":"I believe in writing content Informing investors with the knowledge they need to invest better today- I have been following the markets for many years and was asked to join the team at WallStreetPR.com recently due to my passion for the markets.","sameAs":["http:\/\/www.WallStreetPR.com"],"url":"https:\/\/cablemanpro.com\/wallstreetpr\/author\/darcie-fago"}]}},"_links":{"self":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts\/43823","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/comments?post=43823"}],"version-history":[{"count":0,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts\/43823\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/media\/41971"}],"wp:attachment":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/media?parent=43823"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/categories?post=43823"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/tags?post=43823"},{"taxonomy":"stock_ticker","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/stock_ticker?post=43823"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}